Articles in section Licensing
| << Joint Venture | 539 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 54 | Next >> |
-
Madrigal Inks US$50 M Deal with Pfizer for DGAT-2 inhibitor Ervogastat for the Treatment of MASH
-
Pfizer Secures US$2.09 B Licensing Agreement for YaoPharma’s Weight Management Candidate
-
Gilead’s Kite Signs US$1.64 B In Vivo CAR-T Deal with Pregene Biopharma
-
Novo Nordisk Expands Rare Disease Pipeline with US$2.4 B Omeros Partnership
-
AbbVie Signs US$1.225 B Licensing Pact with IGI Therapeutics for Oncology and Autoimmune Disease Treatment
-
Gilead Sciences Inks US$750 M Deal with Kymera Therapeutics for Novel Oral Molecular Glue CDK2 Degraders
-
Lilly Signs US$870 M Licensing Pact with Camurus for Long-Acting FluidCrystal® Incretins
-
Astellas Signs US$1.5 B Deal with Evopoint Biosciences for Novel CLDN18.2 ADC
-
Regeneron Inks US$2.01 B Deal for Hansoh’s Late-Stage Obesity Drug Candidate
-
Pfizer and 3SBio Forge US$6 B Oncology Alliance to Advance Bispecific Antibody Therapy
RSS